Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About Trupanion Inc (TRUP)

The third quarter was a rough one for most investors, as fears of an interest rate hike in the U.S, a weakening economy in China, and a stagnant Europe, weighed heavily on the minds of investors. Both the S&P 500 and Russell 2000 sank as a result, with the Russell 2000, which is composed of smaller companies, being hit especially hard. This was primarily due to hedge funds, which are big supporters of small-cap stocks, pulling some of their capital out of the volatile markets during this time. Let’s look at how this market volatility affected the sentiment of hedge funds towards Trupanion Inc (NYSE:TRUP), and what that likely means for the prospects of the company and its stock.

Is Trupanion Inc (NYSE:TRUP) worth your attention right now? Investors who are in the know are taking a bearish view. The number of bullish hedge fund positions retreated by 3 recently. At the end of this article we will also compare TRUP to other stocks, including Gladstone Investment Corporation (NASDAQ:GAIN), Second Sight Medical Products Inc (NASDAQ:EYES), and SeaChange International (NASDAQ:SEAC) to get a better sense of its popularity.

Follow Trupanion Inc. (NYSE:TRUP)
Trade (NYSE:TRUP) Now!

In the eyes of most stock holders, hedge funds are assumed to be worthless, old investment vehicles of years past. While there are more than 8000 funds in operation today, Our researchers choose to focus on the bigwigs of this club, approximately 700 funds. These investment experts shepherd bulk of the hedge fund industry’s total capital, and by following their first-class picks, Insider Monkey has unearthed a number of investment strategies that have historically defeated Mr. Market. Insider Monkey’s small-cap hedge fund strategy exceeded the S&P 500 index by 12 percentage points per year for a decade in their back tests.

Now, we’re going to take a gander at the fresh action regarding Trupanion Inc (NYSE:TRUP).

How have hedgies been trading Trupanion Inc (NYSE:TRUP)?

Heading into Q4, a total of 5 of the hedge funds tracked by Insider Monkey held long positions in this stock, a slump of 38% from the previous quarter. With hedgies’ sentiment swirling, there exists an “upper tier” of noteworthy hedge fund managers who were boosting their holdings considerably (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, Deerfield Management, managed by James E. Flynn, holds the number one position in Trupanion Inc (NYSE:TRUP). According to its latest quarterly report, the fund has a $11.9 million position in the stock, comprising 0.5% of its 13F portfolio. On Deerfield Management’s heels is Ken Griffin of Citadel Investment Group, with a $2.5 million stake; less than 0.1% of its 13F portfolio is allocated to the stock. Remaining peers that are bullish contain Jacob Gottlieb’s Visium Asset Management, Mark N. Diker’s Diker Management and Jim Simons’s Renaissance Technologies.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.